The Big News For Sickle Cell Anemia Is Not Gene Therapy

Global-Blood-Therapeutics-composite-image-SCA-trial-1200x522
image courtesy of Global Blood Therapeutics (as seen in Forbes)

Blood specialists reported on practice-changing studies for sickle cell disease, including a large study of bone marrow transplant from matched sibling donors. A preliminary report looked at effects of GBT440, a novel oral agent that augments hemoglobin’s binding to oxygen.